Β-Thalassemia Treatment with KL003 Cell Injection
Β-Thalassemia Treatment with KL003 Cell Injection
Recruiting · NCT06280378 · Registry updated 2025-03-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Β-Thalassemia Treatment with KL003 Cell Injection | Transfusion-dependent Beta-Thalassemia | Recruiting | Phase 1 / Phase 2 | 2025-03-10 | NCT06280378 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kanglin Biotechnology (Hangzhou) Co., Ltd. | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Hematology & Blood Diseases Hospital | Tianjin | China | 22 |
| Ruijin Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | China | 13 |